Moderna has reported preliminary clinical results with a bivalent version of its COVID-19 vaccine that combines its original version with another targeting the Beta variant, and seems to offer ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for the next flu season ...

“The companies told the PTAB in the petitions that Moderna’s patents include ‘unimaginably broad claims directed to a basic idea.’” Patent Trial and Appeal Board (PTAB) docket entries ...

The bivalent vaccine is designed to defend against BA.1, an Omicron subvariant, and an early strain of the novel coronavirus. Pfizer Inc. and Moderna Inc. have been developing their versions of ...

The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

Moderna did not include potential sales for new products, including its next-generation Covid-19 vaccine, in its 2025 estimates. The team was asked whether this was a reflection of any uncertainty ...

(Reuters) -Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a rare neurological side effect was reported. The trial of the ...

Analysts expect Moderna to report quarterly losses of $2.68 per share and revenue of $942.84 million. COVID-19 vaccine demand and sales will be on watch. Every week, our Whisper Index uncovers ...